Making Millions of Children Strong and Healthy

DYNE Pharma (Shandong DYNE Marine Biopharmaceutical Co., Ltd.) is a medium-sized, state-owned, publicly listed company committed to advancing the health and well-being of children across China. Since its founding in 1994, DYNE Pharma has focused on the research, development, manufacturing, and distribution of pediatric medications, nutritional supplements, and medical devices. With 30 years of dedication, DYNE Pharma has established itself as a pioneer and leader in the children's health sector in China, driving innovation and improving the well-being of children across the nation.

The name “DYNE,” derived from the smallest unit of force in physics, symbolizes the company’s philosophy: “A journey of a thousand miles begins with a single step; a force of ten thousand pounds comes from DYNE.” This reflects our belief that great achievements stem from the accumulation of small but meaningful efforts.

Mission and Vision
Guided by our mission to “Make millions of Chinese children strong and healthy”, DYNE Pharma aspires to become the leading enterprise in pediatric care and treatment. We are driven by our core values: diligence, integrity, efficiency, and innovation. Through scientific advancements, long-term cooperation, and unrelenting dedication, we aim to safeguard the health and future of children while promoting a culture of responsibility and excellence.

Innovative Solutions for Pediatric Needs
DYNE Pharma is at the forefront of pediatric pharmaceutical innovation, living up to our commitment to “Make medicines child size.” We have been continuously investing in research and development, establishing cutting-edge R&D platforms for inhalation products, transdermal patches, taste-masking, extended-release technologies, and suppositories. These advancements enable us to meet the unique needs of children with safe, effective, and tailored solutions.

Our state-of-the-art manufacturing facilities, located in Shandong Province, are designed exclusively for pediatric products. With a production capacity of 4 billion soft capsules annually and recognition such as the TGA A1 rating, we demonstrate our commitment to global quality standards.

Unparalleled Market Presence
With a dedicated pediatric sales team and robust distribution channels, DYNE Pharma reaches across China, from hospitals and pharmacies to mom-and-baby shops and e-commerce platforms. Our flagship brand, “Yikexin,” is a household name among parents, synonymous with trust and quality. Holding over 60% of the market share in the children’s vitamin AD category, Yikexin reflects our leadership in the pediatric healthcare sector.

Social Responsibility
Over our 30-year journey, we have been fulfilling the social responsibility with actions. Through initiatives like the DYNE Fund, educational programs, and public health campaigns, we actively contribute to societal well-being, demonstrating our unwavering commitment to children’s health.

In October2024, DYNE Pharma, collaborating with various parties, launched the “Care Center for Children with Rare Diseases.” This initiative aims to promote the establishment of a comprehensive system for medication protection, system improvement, public welfare assistance, and patient education services for children with rare diseases, safeguarding their quality of life.

A Global Vision

Looking ahead, DYNE Pharma is committed to expanding its impact beyond China. We are eager to collaborate with international leaders in pediatric pharmaceutical innovation, bringing groundbreaking therapies to China to improve the lives of millions of children. At the same time, we strive to share our high-quality pediatric solutions with children around the globe, making meaningful contributions to the worldwide effort to advance children's health.